As win­ter ap­proach­es, a Eu­ro­pean gener­ics group rais­es alarm over en­er­gy prices for man­u­fac­tur­ers

While cold­er tem­per­a­tures are fast ap­proach­ing, the sit­u­a­tion sur­round­ing the rise of en­er­gy prices in Eu­rope is hit­ting busi­ness­es of every kind, in­clud­ing gener­ic drug man­u­fac­tur­ers.

Med­i­cines for Eu­rope, a group that rep­re­sents the gener­ic in­dus­try on the con­ti­nent, sent a let­ter ad­dressed to en­er­gy min­is­ters and com­mis­sion­ers con­cern­ing in­fla­tion and the costs of en­er­gy on the sup­ply of gener­ic med­i­cines.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER